17.02.2023 - REDWOOD CITY, Calif., Feb. 17, 2023 (GLOBE NEWSWIRE) - Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic . Seite 1
Jasper Therapeutics (JSPR) Appoints Industry Veteran Vishal Kapoor to its Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Jasper Therapeutics Inc (NASDAQ:JSPR – Get Rating) – Equities research analysts at Oppenheimer lowered their FY2022 EPS estimates for Jasper Therapeutics in a research report issued to clients and investors on Monday, March 21st. Oppenheimer analyst J. Olson now expects that the company will earn ($1.18) per share for the year, down from their previous […]
Jasper Therapeutics Inc (NASDAQ:JSPR) Expected to Announce Earnings of -$0 28 Per Share etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.
FinancialNewsMedia.com News Commentary PALM BEACH, Fla., Oct. 14, 2021 /PRNewswire/ The breast cancer drugs market, which has been steadily growing over the past few years, is projected